V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260008577 | 260005721 | 1.75 | 98.1 | Curative (C) | 2015-04-04 | 2015-04-13 | Mitomycin Intravesical | N | N | 260028197 | RITUXIMAB |
| 260008578 | 260005722 | 1.61 | null | null | 2016-03-05 | 2016-03-08 | Rituximab | 02 | null | 260028199 | CHLORAMBUCIL + RITUXIMAB |
| 260008579 | 260005722 | 1.79 | 79 | Palliative (P) | 2015-05-11 | 2015-05-18 | Bendamustine +/- Prednisolone | N | N | 260028199 | CYCLOPHOSPHAMIDE |
| 260008580 | 260005723 | null | 64 | null | 2017-10-28 | 2017-11-24 | R Chlorambucil | N | N | 260028202 | GEMCITABINE |
| 260008581 | 260005723 | 1.5 | null | Disease modification (D) | 2016-10-12 | 2016-10-12 | Rituximab | 02 | N | 260028202 | RITUXIMAB |
| 260008582 | 260005724 | 1.75 | 97 | Curative (C) | 2016-03-30 | 2016-04-03 | Rituximab | 02 | N | 260028205 | RITUXIMAB |
| 260008583 | 260011964 | 1.85 | 81.9 | Adjuvant (A) | 2016-03-14 | 2016-03-15 | Rituximab | N | N | 260028206 | RITUXIMAB |
| 260008584 | 260005725 | null | 107.4 | Curative (C) | 2014-10-25 | 2014-11-09 | Rituximab | 02 | N | 260028207 | RITUXIMAB |
| 260008585 | 260005726 | 1.8 | 80 | Curative (C) | null | 2016-02-21 | Rituximab | null | null | 260028210 | RITUXIMAB |
| 260008586 | 260005727 | 1.52 | 42 | Curative (C) | 2016-10-30 | 2016-11-02 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260028212 | CAPECITABINE + CISPLATIN |
| 260008587 | 260005727 | 1.68 | null | Disease modification (D) | 2017-04-06 | 2017-05-01 | Irinotecan + Modified De Gramont | N | N | 260028212 | PACIFICO TRIAL |
| 260008588 | 260005728 | null | null | Disease modification (D) | 2015-09-04 | 2015-09-15 | Cisplatin + Radiotherapy | N | N | 260028214 | RITUXIMAB |
| 260008589 | 260005728 | 1.72 | 95.8 | Palliative (P) | 2017-01-09 | 2017-01-09 | Rituximab | N | N | 260028214 | RITUXIMAB |
| 260008590 | 260005729 | 1.6 | 75 | Curative (C) | 2015-06-22 | 2015-06-28 | Chlorambucil | 01 | N | 260028217 | CHLORAMBUCIL |
| 260008591 | 260005729 | 1.55 | 70 | Palliative (P) | null | 2017-10-09 | CHOP - 21 days | 02 | N | 260028217 | CYCLOPHOSPHAMIDE + ETOPOSIDE |
| 260008592 | 260005729 | 1.83 | 64.7 | null | 2017-07-15 | 2017-07-16 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 2 | null | 260028217 | BENDAMUSTINE |
| 260008593 | 260005729 | 1.7 | 75 | Curative (C) | 2015-12-31 | 2016-01-02 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 260028217 | ETOPOSIDE + RITUXIMAB |
| 260008594 | 260005730 | null | 57 | Not known (9) | 2017-12-04 | 2017-12-17 | Rituximab | N | N | 260028224 | RITUXIMAB |
| 260008595 | 260011968 | 1.63 | 87 | Not known (9) | null | 2015-07-11 | CHOP - 21 days | null | null | 260028228 | CHOP |
| 260008596 | 260011968 | null | 77.6 | Curative (C) | 2018-07-05 | 2018-07-12 | Fluorouracil + Folinic Acid Weekly | N | N | 260028228 | RITUXIMAB |
| 260008597 | 260005731 | 1.77 | null | Curative (C) | 2018-01-01 | 2018-01-01 | Enzalutamide | N | N | 260028230 | CHLORAMBUCIL + RITUXIMAB |
| 260008598 | 260005732 | 1.64 | 63 | Adjuvant (A) | 2015-01-27 | 2015-01-27 | CISPLATIN + RT | N | N | 260028233 | RITUXIMAB |
| 260008599 | 260005732 | 1.79 | 65 | null | 2015-11-24 | 2015-12-14 | BENDAMUSTINE | 02 | N | 260028233 | CAPECITABINE + RT |
| 260008600 | 260005733 | null | 91 | Curative (C) | 2016-07-25 | 2016-08-01 | GALLIUM TRIAL | N | N | 260028235 | CHLORAMBUCIL + RITUXIMAB |
| 260008601 | 260005734 | null | 83.2 | Curative (C) | null | 2017-07-11 | RCEOP | null | null | 260028236 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260008602 | 260005735 | 1.85 | 91.6 | Curative (C) | 2018-01-28 | 2018-02-02 | CARBOPLATIN + ETOPOSIDE | N | N | 260028238 | CAPECITABINE + OXALIPLATIN |
| 260008603 | 260005735 | 1.82 | 92.6 | Curative (C) | 2014-07-21 | 2014-07-22 | Oxaliplatin + Modified de Gramont | N | N | 260028238 | CISPLATIN + ETOPOSIDE |
| 260008604 | 260005736 | 1.7 | 71.65 | Palliative (P) | 2015-07-12 | 2015-07-18 | CHLORAMBUCIL + RITUXIMAB | N | N | 260028242 | CAPECITABINE |
| 260008605 | 260011971 | 1.67 | 100.4 | Adjuvant (A) | 2017-01-08 | 2017-01-21 | Cisplatin + Etoposide (5 day) | N | N | 260028244 | CISPLATIN + ETOPOSIDE |
| 260008606 | 260011971 | 1.67 | 38.6 | null | 2017-01-23 | 2017-01-23 | Bendamustine +/- Prednisolone | 02 | null | 260028244 | PACIFICO TRIAL |
| 260008607 | 260005737 | 1.7 | null | Curative (C) | 2017-11-15 | 2017-11-19 | Chlorambucil + Pred + Rituximab | N | null | 260028246 | CHLORAMBUCIL + RITUXIMAB |
| 260008608 | 260005737 | 1.78 | 76 | Palliative (P) | 2016-06-12 | 2016-06-16 | BOP | 02 | N | 260028246 | RITUXIMAB |
| 260008609 | 260005737 | null | 69.3 | null | null | 2015-06-12 | Rituximab (Maintenance) | null | null | 260028246 | RITUXIMAB |
| 260008610 | 260005737 | 1.59 | null | null | 2014-09-28 | 2014-09-28 | Rituximab (Maintenance) | null | Y | 260028246 | RITUXIMAB |
| 260008611 | 260005738 | 1.78 | 134.9 | Curative (C) | 2016-04-25 | 2016-05-14 | Rituximab | N | N | 260028253 | RITUXIMAB |
| 260008612 | 260005738 | 1.7 | 77.7 | Curative (C) | 2016-02-09 | 2016-02-21 | Rituximab | 02 | N | 260028253 | CISPLATIN + ETOPOSIDE |
| 260008613 | 260005738 | 1.68 | 74.1 | Palliative (P) | 2015-03-30 | 2015-03-31 | PACIFICO TRIAL | N | N | 260028253 | CHLORAMBUCIL |
| 260008615 | 260011974 | 1.75 | null | Palliative (P) | 2016-06-01 | 2016-06-02 | Rituximab | N | N | 260028265 | CISPLATIN + GEMCITABINE |
| 260008616 | 260005740 | 1.63 | 72 | null | 2016-11-27 | 2016-11-27 | Bendamustine +/- Prednisolone | 02 | N | 260028267 | RITUXIMAB |
| 260008617 | 260011975 | 0 | 73.2 | null | 2015-12-27 | 2015-12-31 | Cisplatin | N | N | 260028269 | BENDAMUSTINE |
| 260008618 | 260005741 | 1.79 | 53.4 | Palliative (P) | 2017-02-07 | 2017-02-16 | Rituximab | N | N | 260028270 | RITUXIMAB |
| 260008619 | 260005741 | 1.75 | 66 | Adjuvant (A) | 2016-10-08 | 2016-10-08 | Chlorambucil | 2 | Y | 260028270 | CARBOPLATIN + ETOPOSIDE |
| 260008620 | 260005742 | 1.65 | 47.7 | Disease modification (D) | null | 2017-06-04 | Carboplatin + Paclitaxel (3 weekly) | N | N | 260028275 | CISPLATIN |
| 260008621 | 260011977 | 1.65 | 54.8 | Disease modification (D) | 2014-02-11 | 2014-02-15 | BENDAMUSTINE | Y | N | 260028277 | RITUXIMAB |
| 260008622 | 260005743 | 1.72 | 55.7 | Palliative (P) | 2018-05-02 | 2018-05-02 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 02 | N | 260028278 | GEFITINIB |
| 260008625 | 260011979 | 1.69 | null | Curative (C) | 2017-02-23 | 2017-03-11 | Rituximab | N | N | 260028281 | RITUXIMAB |
| 260008626 | 260011979 | 1.85 | 65 | Curative (C) | 2016-02-04 | 2016-02-17 | Rituximab (Maintenance) | 2 | N | 260028281 | RITUXIMAB |
| 260008627 | 260005745 | 1.58 | 145.4 | Curative (C) | 2014-07-21 | 2014-07-27 | Rituximab | N | N | 260028283 | ETOPOSIDE |
| 260008628 | 260005745 | 1.86 | 56.6 | null | null | 2014-12-07 | CAPECITABINE + RT | N | null | 260028283 | RITUXIMAB |
| 260008629 | 260005746 | null | null | null | 2016-09-17 | 2016-09-17 | Hydroxycarbamide | N | N | 260028286 | IRINOTECAN + MDG |